These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 36189307)

  • 1. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
    Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
    Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
    He L; Yang H; Huang J
    BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
    Yang H; Zhao L; Zhang Y; Li FF
    Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
    Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
    Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
    Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
    Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
    Zhang X; Wen Z; Wang Q; Ren L; Zhao S
    Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
    Xu F; Yan J; Peng Z; Liu J; Li Z
    Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
    Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
    J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma.
    Zhang K; Lu S; Jiang M; Zou X; Chen C; Lan Y; Zhao H; Ma R; Yan H
    Front Biosci (Landmark Ed); 2024 May; 29(5):193. PubMed ID: 38812298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.
    Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
    Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
    Li G; Lei J; Xu D; Yu W; Bai J; Wu G
    Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction.
    Zhu J; Yuan J; Arya S; Du Z; Liu X; Jia J
    Front Immunol; 2023; 14():1265098. PubMed ID: 38169731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel aging-associated lncRNA signature for predicting prognosis in osteosarcoma.
    He Y; Huang X; Ma Y; Yang G; Cui Y; Lv X; Zhao R; Jin H; Tong Y; Zhang X; Li J; Peng M
    Sci Rep; 2024 Jan; 14(1):1386. PubMed ID: 38228673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.